Science · 3 views
Scientists Separated Psilocybin's Brain Benefits From Its Hallucinogenic Trip
Psilocybin, the psychedelic compound in 'magic mushrooms', is being looked at for treatments for depression and post-traumatic stress disorder (PTSD).
AI Summary
Scientists are studying psilocybin, the psychedelic compound in magic mushrooms, as a potential treatment for depression and post‑traumatic stress disorder. Researchers aim to isolate any therapeutic brain effects from the hallucinogenic experience typically produced by the drug.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Science
Continue reading recent Science coverage
- Clearer environmental benefits could encourage green EV insurance purchasesContinue reading
- Virtual tourism could get more realistic: Model builds panoramasContinue reading
- COP31: Will this year’s climate summit be the most underwhelming ever?Continue reading
- Enzyme found to have surprising role in earliest infant gut microbiome developmentContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow